The historical rank and industry rank for Nuo Therapeutics's Net Margin % or its related term are showing as below:
AURX'
s Net Margin % Range Over the Past 10 Years
Min: -2832.14 Med: -520.69 Max: -112.47
Current: -521.71
AURX's Net Margin % is ranked worse than 65.82% of 1027
companies
in the Biotechnology industry
Industry Median: -160.92
vs AURX: -521.71
Nuo Therapeutics Net Margin % Historical Data
The historical data trend for Nuo Therapeutics's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nuo Therapeutics's Net Margin %
For the Biotechnology subindustry, Nuo Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nuo Therapeutics's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nuo Therapeutics's Net Margin % distribution charts can be found below:
* The bar in red indicates where Nuo Therapeutics's Net Margin % falls into.
Nuo Therapeutics Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Nuo Therapeutics's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nuo Therapeutics (OTCPK:AURX) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Nuo Therapeutics Net Margin % Related Terms
Thank you for viewing the detailed overview of Nuo Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nuo Therapeutics (Nuo Therapeutics) Business Description
Nuo Therapeutics Inc is a regenerative therapies company focused on developing and marketing products for chronic wound care primarily within the U.S. Company's commercialize innovative cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The company derives revenues from the sale of the Aurix product to customers consisting of primarily hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The Aurix product became commercially available for sale in current financial year.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AURX has been successfully added to your 